Viewing Study NCT02819804


Ignite Creation Date: 2025-12-24 @ 8:03 PM
Ignite Modification Date: 2025-12-25 @ 5:36 PM
Study NCT ID: NCT02819804
Status: TERMINATED
Last Update Posted: 2020-02-11
First Post: 2016-06-28
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Sponsor: Northwestern University
Organization: